Acute renal failure in a patient receiving anti-VEGF therapy for advanced non-small cell lung cancer

Journal of Thoracic Oncology

Volumn 4, Issue 9, 2009, Pages 1185-1187

  Zhao, Jing ^a   Li, Hang ^a   Wang, Mengzhao ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CARBOPLATIN; CREATININE; GEFITINIB; PACLITAXEL; VASCULOTROPIN ANTIBODY;

ACUTE KIDNEY FAILURE; ADVANCED CANCER; AGED; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; ECHOGRAPHY; ERYTHROCYTE; HEMODIALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FUNCTION; LABORATORY TEST; LETTER; LUNG NON SMALL CELL CANCER; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MULTIPLE CYCLE TREATMENT; OLIGURIA; PRIORITY JOURNAL; SMOKING; URINALYSIS;

ACUTE KIDNEY INJURY; AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; MALE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 69549107628     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181b2362f     Document Type: Letter

References (7)

1. Suzuki H, Inoue T, Matsushita T, et al. In vitro gene expression analysis of nephrotoxic drugs in rat primary renal cortical tubular cells. J Appl Toxicol 2008;28:237-248.
2. George BA, Zhou XJ, Toto R. Nephrotic syndrome after bevacizumab: case report and literature review. Am J Kidney Dis 2007;49:E23-E29. (Pubitemid 46164815)
3. Barakat RK, Singh N, Lal R, Verani RR, Finkel KW, Foringer JR. Interstitial nephritis secondary to bevacizumab treatment in metastatic leiomyosarcoma. Ann Phamacother 2007;41:707-710. (Pubitemid 46625498)
4. Johnson DH, Fehrenbacher L, Novotny WF, et al. Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol 2004;22:2184-2191. (Pubitemid 41095154)
5. Frangie C, Lefaucheur C, Medioni J, Jacquot C, Hill GS, Nochy D. Renal thrombotic microangiopathy caused by anti-VEGF-antibody treatment for metastatic renal-cell carcinoma. Lancet Oncol 2007;8:177-178. (Pubitemid 46158384)
6. Roncone D, Satoskar A, Nadasdy T, Monk JP, Rovin BH. Proteinuria in a patient receiving anti-VEGF therapy for metastatic renal cell carcinoma. Nat Clin Pract Nephrol 2007;3:287-293. (Pubitemid 46674523)
7. Eremina V, Jefferson JA, Kowalewska J, et al. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 2008;358:1129-1136.